mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |